The acute treatment of episodic and chronic migraine in the USA

Cephalalgia

Volumn 29, Issue 8, 2009, Pages 891-897

  Bigal, Me ^a,b,d   Borucho, S ^b   Serrano, D ^c   Lipton, Rb ^b  

^a MERCK RESEARCH LABORATORIES   (United States)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^c VEDANTA RESEARCH   (United States)

^d NONE   (United States)

Author keywords

Acute treatment; Chronic migraine therapy; Migraine therapies

Indexed keywords

ACETYLSALICYLIC ACID; BARBITURIC ACID DERIVATIVE; BUTALBITAL; CODEINE; ERGOTAMINE; IBUPROFEN; ISOMETHEPTENE; NAPROXEN; NONSTEROID ANTIINFLAMMATORY AGENT; OPIATE DERIVATIVE; PARACETAMOL; RIZATRIPTAN; SUMATRIPTAN; TRIPTAN DERIVATIVE; ZOLMITRIPTAN;

ADULT; ARTICLE; CONFIDENCE INTERVAL; DRUG USE; FEMALE; HEADACHE; HUMAN; MAJOR CLINICAL STUDY; MALE; MIGRAINE; PRESCRIPTION; QUESTIONNAIRE; TRANSFORMED MIGRAINE; UNITED STATES;

EID: 67650317926     PISSN: 03331024     EISSN: 14682982     Source Type: Journal    
DOI: 10.1111/j.1468-2982.2008.01819.x     Document Type: Article

References (23)

1. Lipton RB, Stewart WF, Diamond S, Diamond ML, Reed M. Prevalence and burden of migraine in the United States: data from the American Migraine Study II. Headache 2001 41 : 646 57.
2. Lipton RB, Bigal ME, Diamond M, Freitag F, Reed ML, Stewart WF Migraine prevalence, disease burden, and the need for preventive therapy. Neurology 2007 68 : 343 9.
3. Rasmussen BK. Epidemiology of headache. Cephalalgia 1995 15 : 45 68.
4. Diamond MD, Bigal ME, Silberstein S, Loder E, Reed M, Lipton RB. Patterns of diagnosis and acute and preventive treatment for migraine in the United States: results from the American Migraine Prevalence and Prevention Study. Headache 2007 47 : 355 63.
5. Osterhaus JT, Gutterman DL, Plachetka JR. Health care resources and lost labor costs of migraine headaches in the United States. Pharmacoeconomics 1992 2 : 67 76.
6. Headache Classification Subcommittee of the International Headache Society. The International Classification of Headache Disorders, 2nd edn. Cephalalgia 2004 24 (Suppl. 1 1 15.
7. Silberstein SD, Lipton RB, Sliwinski M. Classification of daily and near-daily headaches: field trial of revised IHS criteria. Neurology 1996 47 : 871 5.
8. Bigal ME, Rapoport AM, Lipton RB, Tepper SJ, Sheftell FD. Assessment of migraine disability using the migraine disability assessment (MIDAS) questionnaire: a comparison of chronic migraine with episodic migraine. Headache 2003 43 : 336 42.
9. Silberstein S, Loder E, Diamond S, Reed ML, Bigal ME, Lipton RB Probable migraine in the United States: results of the American Migraine Prevalence and Prevention (AMPP) study. Cephalalgia 2007 27 : 220 34.
10. Liebestein M, Bigal ME, Sheftell FD, Rapoport AM, Tepper SJ. Validation of the chronic daily headache questionnaire. Neurology 2007 68 (Suppl. 1 369.
11. Ferrari MD. The economic burden of migraine to society. Pharmacoeconomics 1998 13 : 667 76.
12. Stewart WF, Lipton RB, Simon D. Work-related disability: results from the American Migraine study. Cephalalgia 1996 16 : 231 8.
13. Michel P, Dartigues JF, Lindousli A, Henry P. Loss of productivity and quality of life in migraineurs among French workers: results from the GAZEL cohort. Headache 1997 37 : 71 8.
14. Lucas C, Chaffaut C, Artaz MA, Lanteri-Minet M. FRAMIG 2005: medical and therapeutic management of migraine in France. Cephalalgia 2005 25 : 267 79.
15. Pavone E, Banfi R, Vaiani M, Panconesi A. Patterns of triptans use: a study based on the records of a community pharmaceutical department. Cephalalgia 2007 27 : 1000 4.
16. Morillo LE, Alarcon F, Aranaga N, Aulet S, Chapman E, Conterno L et al. Clinical characteristics and patterns of medication use of migraineurs in Latin America from 12 cities in 6 countries. Headache 2005 45 : 118 26.
17. Matchar DB, Young WB, Rosenerg J, Pietrzack MP, Silberstein SD, Lipton RB, Ramadan N. Multispecialty consensus on diagnosis and treatment of headache: pharmacological management of acute attacks. Available at http://www.aan.com/ professionals/practice/pdfs/gl0087.pdf (accessed November 2008).
18. Bahra A, Walsh M, Menon S, Goadsby PJ. Does chronic daily headache arise de novo in association with regular use of analgesics? Headache 2003 43 : 179 90.
19. Wilkinson SM, Becker WJ, Heine JA. Opiate use to control bowel motility may induce chronic daily headache in patients with migraine. Headache 2001 41 : 303 9.
20. Compton WM, Volkow ND. Major increases in opioid analgesic abuse in the United States: concerns and strategies. Drug Alcohol Depend 2006 81 : 103 7.
21. Bigal ME, Rapoport AM, Sheftell FD, Tepper SJ, Lipton RB. Transformed migraine and medication overuse in a tertiary headache centre - clinical characteristics and treatment outcomes. Cephalalgia 2004 24 : 483 90.
22. Stang PE, Yanagihara T, Swanson JW, Beard CM, O'Fallon WM, Guess HA, Melton LJ 3rd. Incidence of migraine headaches: a population-based study in Olmsted County, Minnesota. Neurology 1992 42 : 1657 62.
23. Stovner LJ, Zwart JA, Hagen K, Terwindt GM, Pascual J. Epidemiology of headache in Europe. Eur J Neurol 2006 13 : 333 45.